REFERENCES
- Hawkey PM. Resistant bacteria in the normal human flora. J Antimicrob Chemother 1986; 18: 133–9.
- Edlund C, Nord CE. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol J 1993; 2: 137–164.
- Edlund C, Sjöstedt S, Nord CE. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis 1997; 29: 383–386.
- Ritz M, Lode H, Fassbender M, Borner K, Koeppe P, Nord CE. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother 1994; 38: 455–459.
- Wise R, Brenwald NP, Andrews JM, Boswell F. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. J Antimicrob Chemother 1997; 39: 447–452.
- Bauernfeind A. Comparison of the antibacterial activities of quinolones Bay 12-8039, gatifloxacin, trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639–51.
- Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 1979; 11: 233–242.
- van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Ann Rev Microbiol 1989; 43: 69–87.
- Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409–14.
- Edlund C, Lindqvist L, Nord CE. Norfloxacin binds to human fecal material. Antimicrob Agents Chemother 1988; 32: 1869–74.
- Ljungberg B, Nilsson-Ehle I, Edlund C, Nord CE. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption. Scand J Infect Dis 1990; 22: 205–8.
- Kresken M, Hafner D, Mittermayer H, et al. Prevalence of fluoroquinolone resistance in Europe. Infection 1994; 22 (suppl 2): 90-8.